# Enzymedica

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enzymedica

- Industry: Biopolymers
- Headquarters: Venice, US
- Website: www.enzymedica.com
- Total disclosed funding: $23M
- Latest round: Series A (Nov 15, 2013)
- Investors on record: 1

## About

Enzymedica, Inc. is a specialized company dedicated to digestive health, offering enzyme-based supplements that enhance digestive function and overall wellness for a diverse range of health-conscious consumers.Founded in 1998 and headquartered in Venice, US, Enzymedica focuses on providing enzyme-based digestive health supplements. The company has raised a total of USD 23.49 mn in funding through a SERIES A round on November 15, 2013, with NGEN Partners as a key investor. Scott Sensenbrenner serves as CEO, driving the company’s vision and operations.Enzymedica® specializes in digestive health supplements, which include products such as Digest Gold®, Digest Complete®, and Lypo Gold™. These enzyme-based products are formulated to address specific digestive issues like gas, bloating, and food intolerance, using high-quality, scientifically validated ingredients. The company markets its products both domestically and internationally to health-conscious consumers.Enzymedica® generates revenue through direct-to-consumer sales and partnerships with retailers. Their sales model includes one-time purchases and subscription options, enhancing customer loyalty. Core products like Digest Gold® and Digest Complete® are competitively priced to attract a wide audience while maintaining premium quality, driving repeat business.Enzymedica plans to leverage the recent SERIES A funding of USD 23.49 mn raised in November 2013 to expand its product line and enter new markets. The company is developing new products aimed at addressing a broader range of digestive health needs, with anticipated launches by the end of 2024. Additionally, Enzymedica is targeting expansion into European and Asian markets to enhance its global reach.

## Funding rounds

- Series A, Nov 15, 2013, $23M — NGEN Partners

## Investors

- NGEN Partners (https://capitalatlas.ai/funds/ngen-partners) — Series A